Author:
Le Merdy Maxime,Fan Jianghong,Bolger Michael B.,Lukacova Viera,Spires Jessica,Tsakalozou Eleftheria,Patel Vikram,Xu Lin,Stewart Sharron,Chockalingam Ashok,Narayanasamy Suresh,Rouse Rodney,Matta Murali,Babiskin Andrew,Kozak Darby,Choi Stephanie,Zhang Lei,Lionberger Robert,Zhao Liang
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Center for Drug Evaluation and Research. Generic drug user fee amendments [Internet]. [cited 2018 Dec 14]. Available from:
https://www.fda.gov/ForIndustry/UserFees/GenericDrugUserFees/default.htm
. Accessed 30 Apr 2019.
2. US. FDA. Bioavailability and bioequivalence studies for orally administered drug products—general considerations [Internet]. 2003. Available from:
https://www.fda.gov/media/87219/download
. Accessed 30 Apr 2019.
3. Choi SH, Lionberger RA. Clinical, pharmacokinetic, and in vitro studies to support bioequivalence of ophthalmic drug products. AAPS J. 2016;18(4):1032–8.
https://doi.org/10.1208/s12248-016-9932-z
.
4. Orange book: approved drug products with therapeutic equivalence evaluations [Internet]. [cited 2018 Dec 14]. Available from:
https://www.accessdata.fda.gov/scripts/cder/ob/
. Accessed 30 Apr 2019.
5. Ali Y, Lehmussaari K. Industrial perspective in ocular drug delivery. Adv Drug Deliv Rev. 2006 Nov 15;58(11):1258–68.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献